Benutzer: Gast  Login
Titel:

Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.

Dokumenttyp:
Journal Article; Research Support, Non-U.S. Gov't
Autor(en):
Greve, J; Hoffmann, TK; Schüler, P; Lang, S; Chaker, A; Bas, M
Abstract:
Hereditary angioedema (HAE) is a rare, autosomal dominant disorder caused by a C1-esterase inhibitor (C1-INH) deficiency (type 1) or qualitative defect (type 2). It is characterized by recurrent subcutaneous or submucosal edema attacks in various organs with a frequency from a few attacks to over one hundred attacks per year.We report on the treatment of 141 attacks in a patient with hereditary angioedema with the bradykinin B2 receptor antagonist icatibant.During the entire observation period,...     »
Zeitschriftentitel:
Int J Dermatol
Jahr:
2011
Band / Volume:
50
Heft / Issue:
10
Seitenangaben Beitrag:
1294-5
Sprache:
eng
Volltext / DOI:
doi:10.1111/j.1365-4632.2011.05051.x
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/21950301
Print-ISSN:
0011-9059
TUM Einrichtung:
Hals-Nasen-Ohrenklinik und Poliklinik; Molekulare Allergologie (Prof. Schmidt-Weber)
 BibTeX